In order to identify the circRNA that is critical for CRC immune evasion and anti-PD-1 efficacy and tumor progression, the circRNAs up-regulated in both anti-PD-1 resistant and tumor tissues were validated by RT-PCR analysis [Figure 1C]. Here, PDCD1 is linked to neoplasm.